NGF-driven re-activation of the insulin pathway through disinhibition and tyrosine phosphorylation of IRS1, a primary gatekeeper in insulin signaling, is a potential novel strategy to slow cognitive decline in AD and diabetes-related brain insulin resistance. The gene discussed is IRS1; the disease is Alzheimer disease.